eCite Digital Repository

Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic research

Citation

Critchley, CR and Fleming, J and Nicol, D and Marlton, P and Ellis, M and Devereux, L and Bruce, G and Kerridge, I, Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic research, European Journal of Human Genetics, 29, (3) pp. 503-511. ISSN 1018-4813 (2021) [Refereed Article]

Copyright Statement

The Author(s), under exclusive licence to European Society of Human Genetics 2021.

DOI: doi:10.1038/s41431-020-00746-0

Abstract

Various forms of private investment are considered necessary for the sustainability of biobanks, yet pose significant challenges to public trust. To manage this tension, it is vital to identify the concerns of relevant stakeholders to ensure effective and acceptable policy and practice. This research examines the aspects of commercialisation that are of most concern to the Australian public (n = 800) and patients who had donated their tissue to two large disease specific (cancer) public biobanks (n = 564). Overall, we found a commercialisation effect (higher support for public relative to private) in relation to funding, research location and access to stored biospecimens. The effect was strongest for research locations and access compared to funding. A latent class analysis revealed the pattern of concern differed, with the majority (34.1%) opposing all aspects of commercialisation, a minority supporting all (15.7%), one quarter (26.8%) opposing some (sharing and selling tissue) but not others (research locations and funding), and a group who were unsure about most aspects but opposed selling tissue (23.5%). Patient donors were found to be more accepting of and unsure about most aspects of commercialisation. Members of the (general) public who were motivated to participate in biobanking were more likely to oppose some aspects while supporting others, while those who indicated they would not donate to a biobank were more likely to oppose all aspects of commercialisation. The results suggest that approaches to policy, engagement and awareness raising need to be tailored for different publics and patient groups to increase participation.

Item Details

Item Type:Refereed Article
Research Division:Biological Sciences
Research Group:Biochemistry and cell biology
Research Field:Analytical biochemistry
Objective Division:Expanding Knowledge
Objective Group:Expanding knowledge
Objective Field:Expanding knowledge in the biological sciences
UTAS Author:Critchley, CR (Associate Professor Christine Critchley)
UTAS Author:Nicol, D (Professor Dianne Nicol)
ID Code:152860
Year Published:2021
Web of Science® Times Cited:2
Deposited By:Mathematics
Deposited On:2022-08-25
Last Modified:2022-11-21
Downloads:0

Repository Staff Only: item control page